Trials / Conditions / PNH - Paroxysmal Nocturnal Hemoglobinuria
PNH - Paroxysmal Nocturnal Hemoglobinuria
4 registered clinical trials studyying PNH - Paroxysmal Nocturnal Hemoglobinuria — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Study of NM8074 in Soliris-Treated Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) NCT05731050 | NovelMed Therapeutics | Phase 2 |
| Recruiting | A Phase II Study Evaluating the Efficacy and Safety of XH-S003 Capsules in Patients With Paroxysmal Nocturnal NCT06978699 | S-INFINITY Pharmaceuticals Co., Ltd | Phase 2 |
| Active Not Recruiting | Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in PNH Patients. NCT07212426 | Longbio Pharma | Phase 2 |
| Recruiting | A Phase Ib, Multicenter, Open-Label Study of Multiple-Dose EA5 in Adults With Paroxysmal Nocturnal Hemoglobinu NCT07256301 | Shanghai Lanyi Therapeutics Co., Ltd. | Phase 1 |